330 main st. holdings, LLC

409 taughannock blvd
ithaca, new york 14850

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 02, 2014

NYS DOS ID#
4571340

County
TOMPKINS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - 330 MAIN ST. HOLDINGS, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
    Tuesday Jun 13, 2017

    Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.

    Source: The Wall Street Journal: U.S. Business
  • Holding Back TV News? Not For Sweeps Or Main Newscasts
    Tuesday May 16, 2017

    Media viewers shouldn't be teasing into waiting for those big TV news stories that come around four times a year, during sweeps. Trouble is, traditional local TV programming is still where TVstations' bread is buttered -- where they make the most bang for their buck with advertisers.

    Source: Media Post: TV Watch
  • Belgium Holds Four for Questioning in Terror Probe
    Thursday Jun 22, 2017

    Belgian federal prosecutors said four people were taken into custody for questioning as part of a probe into the attempted terrorist attack at Brussels’ main train station earlier this week.

    Source: The Wall Street Journal: World News
  • Greg David on NY: Why developing in Midtown remains a Herculean task
    Monday Jun 19, 2017



    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • Pulse@MassChallenge Spurs Deals in Digital Health Lab’s 1st Session
    By Jeff Engel - Wednesday Jun 14, 2017

    The refrain among digital health startups is it can be difficult and time-consuming to convince hospitals and other healthcare organizations to try out their products, let alone buy them. Pulse@MassChallenge, a new Boston “lab” dedicated to supporting digital health ventures, matches startups with partner organizations—think hospitals, insurers, larger tech companies, nonprofits, and government entities—to collaborate […]

    Source: Xconomy VC, Deals, & Startups Feed
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • New Approvals Show FDA Is Adapting to Precision Medicine
    By Frank Vinluan - Tuesday May 30, 2017

    The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new experimental treatments. Randomized trials are long, expensive to run, and ultimately produce limited answers, she said at a medical conference last week. The […]

    Source: Xconomy New York
  • Getting an Edge in the Long Afghan Struggle
    Friday Jun 23, 2017

    Trump’s early approach holds promise if backed with a sustained, and sustainable, commitment.

    Source: The Wall Street Journal: Opinion